Patent 8158430 was granted and assigned to Theranos on April, 2012 by the United States Patent and Trademark Office.
The present invention provides fluidic devices and systems that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.